Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Yasufumi, Matsuda"'
Autor:
Yasufumi Matsuda
Publikováno v:
Journal of Epidemiology, Vol 26, Iss 1, Pp 30-35 (2016)
Externí odkaz:
https://doaj.org/article/4af8aeea1d524cb4a6625eaa7ab73ce0
Autor:
Miyuki Ookura, Yasufumi Matsuda, Mihoko Morita, Kazuhiro Itoh, Takahiro Yamauchi, Naoko Hosono, Hiroaki Araie
Publikováno v:
International Journal of Hematology. 113:362-369
We retrospectively evaluated the clinical efficacy and toxicity of gemtuzumab ozogamicin (GO) in patients with relapsed acute myeloid leukemia (AML). Nineteen patients (median 70 years) received GO (9 mg/m2, days 1 and 15) as salvage therapy in our i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c74ce6143e21bc1657d586e110554fb
https://doi.org/10.1007/s12185-020-03023-4
https://doi.org/10.1007/s12185-020-03023-4
Autor:
Jun Imagawa, Yoshiaki Chinen, Toru Kiguchi, Chisaki Mizumoto, Katsumichi Fujimaki, Toshihiro Fukushima, Masayuki Mita, Kazunori Murai, Satoshi Wakita, Takayuki Ikezoe, Satoshi Kimura, Chikashi Yoshida, Takaaki Ono, Takeshi Kondo, Atsushi Kawaguchi, Junichi Sakamoto, Ayako Takamori, Jun Aoki, Katsuhiro Io, Kaori Karimata, Yasufumi Matsuda, Kaichi Nishiwaki, Kensuke Usuki, Hirohiko Shibayama, Joji Shimono, Takashi Kumagai, Tomoharu Takeoka, Junya Kuroda, Shinya Kimura, Masatomo Miura, Kensuke Nakao, Yousuke Minami, Nobuhiko Uoshima, Hiroshi Ureshino, Koiti Inokuchi, Hideo Tanaka
Publikováno v:
The Lancet. Haematology. 8(12)
Summary Background BCR-ABL1 tyrosine kinase inhibitors (TKIs) are commonly initiated in older patients with chronic myeloid leukaemia in the chronic phase at standard doses. However, because of their safety profile in this population, appropriate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e609cd0305848ad101ef873748a2dc
https://pubmed.ncbi.nlm.nih.gov/34826413
https://pubmed.ncbi.nlm.nih.gov/34826413
Autor:
Yumie Ebita, Yoshimasa Urasaki, Yasufumi Matsuda, Koji Suzuki, Shiho Masunaga, Yusei Ohshima, Haruka Sakai, Yoko Kobayashi, Kana Oiwa, Miki Matsubara, Shigetake Toyooka, Miyuki Okura, Takahiro Yamauchi
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 65:590-594
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::715a479295e1369420afb5b7be97c163
https://doi.org/10.3925/jjtc.65.590
https://doi.org/10.3925/jjtc.65.590
Autor:
Eiju Negoro, Takahiro Yamauchi, Miyuki Ookura, Yasufumi Matsuda, Katsunori Tai, Misato Kawamichi, Mihoko Morita, Shin Lee, Kei Fujita, Kana Oiwa, Naoko Hosono, Takanori Ueda
Publikováno v:
GOUT AND NUCLEIC ACID METABOLISM. 42:157-164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62af39b8637109ba0f12da289b925aa4
https://doi.org/10.6032/gnam.42.157
https://doi.org/10.6032/gnam.42.157
Autor:
Nobuhiko Uoshima, Masayuki Mita, Chisaki Mizumoto, Hiroshi Ureshino, Satoshi Wakita, Hirohiko Shibayama, Koiti Inokuchi, Satoshi Kimura, Kaori Karimata, Kensuke Nakao, Joji Shimono, Toru Kiguchi, Kaichi Nishiwaki, Hideo Tanaka, Katsumichi Fujimaki, Takayuki Ikezoe, Katsuhiro Io, Takashi Kumagai, Toshihiro Fukushima, Atsushi Kawaguchi, Yoshiaki Chinen, Yasufumi Matsuda, Ayako Takamori, Kazunori Murai, Jun Aoki, Yosuke Minami, Takaaki Ono, Takeshi Kondo, Chikashi Yoshida, Junya Kuroda, Junichi Sakamoto, Tomoharu Takeoka, Shinya Kimura, Masatomo Miura, Kensuke Usuki, Jun Imagawa
Publikováno v:
Blood. 138:3601-3601
Introduction: Tyrosine kinase inhibitors (TKIs) dramatically improved the prognosis of chronic myelogenous leukemia (CML), as nearly half of CML patients presenting with a deep molecular response (DMR) over several years could achieve treatment-free
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c38884d0460be847bad457c47eec50c
https://doi.org/10.1182/blood-2021-149483
https://doi.org/10.1182/blood-2021-149483
Autor:
Yumie Ebita, Tadakazu Okoshi, Yasufumi Matsuda, Yoshiaki Imamura, Yoshimasa Urasaki, Katsunori Tai, Takahiro Yamauchi, Kana Oiwa, Shinji Kishi
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 63:607-613
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66d88fd0251f7b618bccef7cf5899949
https://doi.org/10.3925/jjtc.63.607
https://doi.org/10.3925/jjtc.63.607
Autor:
Mihoko Morita, Miyuki Okura, Takahiro Yamauchi, Kei Fujita, Yasufumi Matsuda, Misato Kawamichi, Eiju Negoro, Kana Oiwa, Naoko Hosono, Takanori Ueda, Katsunori Tai
Publikováno v:
GOUT AND NUCLEIC ACID METABOLISM. 41:183-190
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea244cc13ba6ec28d5d013657fe522df
https://doi.org/10.6032/gnam.41.183
https://doi.org/10.6032/gnam.41.183
Autor:
Koji Morinaga, Rie Nishi, Taira Maekawa, Naoko Hosono, Takanori Ueda, Shinya Kimura, Yasufumi Matsuda, Akira Yoshida, Eiju Negoro, Takahiro Yamauchi, Kanako Uzui
Publikováno v:
Cancer Science
The major mechanism of imatinib (IM) resistance of CML is the reactivation of ABL kinase either through BCR‐ABL gene amplification or mutation. We investigated the cytotoxicity of a pan‐ABL tyrosine kinase inhibitor, ponatinib, and a pan‐histon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30effb93db91d1da8bcd322ebb3f733a
http://europepmc.org/articles/PMC4946706
http://europepmc.org/articles/PMC4946706
Autor:
Yasufumi Matsuda, Koh Miura, Kennichi Satoh, Hiroyuki Sasaki, Michiaki Unno, Munenori Nagao, Takeshi Naitoh, Naoki Tanaka, Junko Yamane, Hiroshi Shima, Kazuyuki Ishida, Wataru Fujibuchi, Fumiyoshi Fujishima, Shinobu Ohnuma
Publikováno v:
Cancer Science
An increasingly accepted concept is that the progression of colorectal cancer is accompanied by epithelial-mesenchymal transition (EMT). In our study, in order to characterize the properties of EMT in 16 colorectal cancer cell lines, the cells were f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e543b556d19b959e3003ea3411c8fa3
http://hdl.handle.net/2433/215157
http://hdl.handle.net/2433/215157